New MRI-radiation hybrid machine in Alberta expected to improve cancer treatment by at least 20 per cent
Technology in Alberta that is expected to allow doctors to more accurately and effectively treat cancerous tumours with radiation enters clinical trials next week.
This next step, after 15 years of work, was celebrated in Edmonton on Friday as a "game changer" and "true medical breakthrough."
The LMR, or Linac-MR machine, simultaneously delivers radiotherapy and high-resolution imaging – something researchers say was previously considered impossible because the magnetic field and x-rays of the two machines interfere with each other if placed within 10 metres.
But a tumour's position can shift with a patient's movement, as they go between machines, or even by breathing. So doctors need to use radiation more conservatively to avoid hitting healthy tissue or organs near a tumour, which in turn means lower radiation doses and a higher number of treatment sessions.
"Say I know exactly where the tumour is without killing healthy tissue: We can calculate the cure rates will improve by 20 to 40 per cent for all solid tumours," creator Dr. Gino Fallone told reporters.
The medical physicist at the University of Alberta has been working on the idea with researchers from Edmonton's Cross Cancer Institute and Alberta Health Services since 2008.
Dr. Nawaid Usmani, who will lead the clinical study, also expects the machine will be able to treat tumours that are difficult to access – like prostate, liver, and pancreatic cancers.
"Over the course of your career, it's very rare to be involved in a true innovation, something that revolutionalizes how treatment is administered and is able to offer new treatments to patients," he commented during the news conference at the Cross Cancer Institute.
"I'm very fortunate to have been involved in this innovation as I've been able to witness right before my eyes this concept become a reality."
'VERY OPTIMISTIC'
Usmani's team is hoping to include 100 patients in the LMR's first year-long trial. Five more phases, each with roughly 100 more participants, will follow.
Marvin Bahry, an 84-year-old prostate cancer patient, will be the first-ever clinical trial participant.
Bahry first had prostate cancer around 12 years ago and told CTV News he has "high hopes" to beat it again.
"I'm very optimistic that all of his research and the hard work of Dr. Usmani and other doctors and nurses and so on, will benefit not only me but all the other people who come here," he said.
"Any good that comes out of it from me will benefit others and that's my little contribution to others in this world…I see nothing but good coming out of all of this."
Jordan Turko, a Cross Cancer Institute fundraiser and cancer survivor, echoed Bahry's thoughts: "When I think about innovations like this, it buys folks like me more time."
In April 2022, at 30 years old, he was diagnosed with Stage 4 lung cancer his doctor believes developed over a period of just four months. Nine months of targeted radiation and pill therapy later, he says his cancer has "fully retreated."
"For the average person, as time goes on, you get less of it. It goes on, you get a little older. But for cancer patients, it's ironic that within innovations like this, when we get a little more time," Turko said of the LMR.
"So things like this are a really big deal because they buy a little more time. Which hopefully means that another great innovator will buy more time and give us more moments in our life."
With files from CTV News Edmonton's Amanda Anderson
CTVNews.ca Top Stories
DEVELOPING Person on fire outside Trump's hush money trial rushed away on a stretcher
A person who was on fire in a park outside the New York courthouse where Donald Trump’s hush money trial is taking place has been rushed away on a stretcher.
Mandisa, Grammy award-winning 'American Idol' alum, dead at 47
Soulful gospel artist Mandisa, a Grammy-winning singer who got her start as a contestant on 'American Idol' in 2006, has died, according to a statement on her verified social media. She was 47.
Senators reject field trip to African Lion Safari amid elephant bill study
The Senate legal affairs committee has rejected a motion calling for members to take a $50,000 field trip to the African Lion Safari in southern Ontario to see the zoo's elephant exhibit.
CFIA monitoring for avian flu in Canadian dairy cattle after U.S. discoveries
The Canadian Food Inspection Agency is encouraging veterinarians to keep an eye out for signs of avian influenza in dairy cattle following recent discoveries of cases of the disease in U.S. cow herds.
She set out to find a husband in a year. Then she matched with a guy on a dating app on the other side of the world
Scottish comedian Samantha Hannah was working on a comedy show about finding a husband when Toby Hunter came into her life. What happened next surprised them both.
DEVELOPING G7 warns of new sanctions against Iran as world reacts to apparent Israeli drone attack
Group of Seven foreign ministers warned of new sanctions against Iran on Friday for its drone and missile attack on Israel, and urged both sides to avoid an escalation of the conflict.
'It could be catastrophic': Woman says natural supplement contained hidden painkiller drug
A Manitoba woman thought she found a miracle natural supplement, but said a hidden ingredient wreaked havoc on her health.
After hearing thousands of last words, this hospital chaplain has advice for the living
Hospital chaplain J.S. Park opens up about death, grief and hearing thousands of last words, and shares his advice for the living.
Vancouver firefighter in rehab at home after losing leg to flesh-eating infection overseas
A family trip took a frightening turn for Christopher Won when he was diagnosed with flesh-eating disease while in Hong Kong and now, after weeks of treatment overseas, the Vancouver firefighter is back home recovering.